Quantum-Si Incorporated (Nasdaq: QSI) has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market. The company announced on Oct. 15, 2026, that it received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC confirming the resolution of its compliance status.
Nasdaq determined that the closing bid price of Quantum-Si's common stock remained at or above $1.00 per share for at least 10 consecutive business days. This specific duration met the criteria under Listing Rule 5450(a)(1). Consequently, Nasdaq advised the company that the matter is closed.
Quantum-Si operates as a proteomics company focused on single-molecule protein sequencing. The firm develops a benchtop platform designed to bring single-molecule protein analysis to laboratories. The platform enables real-time kinetic-based detection, allowing researchers to access dynamic, functional protein insights without traditional multistep workflows. Jeff Keyes, Chief Financial Officer, serves as the contact for investor and media inquiries.